AbbVie (NY:ABBV)
192.41
-2.59
(-1.33%)
Streaming Delayed Price
Updated: 10:35 AM EDT, Jul 11, 2025
Add to My Watchlist
Headline News about AbbVie![]() ![]()
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Via Benzinga
![]() ![]()
Is AbbVie Stock a Buy Now?
December 07, 2023
Via The Motley Fool
![]()
Decoding AbbVie's Options Activity: What's the Big Picture?
December 05, 2023
Via Benzinga
![]()
Analyst Ratings for AbbVie
December 01, 2023
Via Benzinga
![]()
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
Via Benzinga
![]() ![]() ![]() ![]()
Health Care Company AbbVie Announces Acquisition of Immunogen
November 30, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AbbVie's Big Buy Of ImmunoGen Opens Doors For Potential Investment Gains
December 04, 2023
Via Talk Markets
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|